A 'Sure Killer' Yields to Medicine

See allHide authors and affiliations

Science  30 Nov 2001:
Vol. 294, Issue 5548, pp. 1813-1814
DOI: 10.1126/science.294.5548.1813

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The clinical course of inhalational anthrax hasn't changed in centuries, although recent events have demonstrated that speedy diagnosis and new drugs can alter its outcome. But unresolved questions linger. Will the survivors face lung problems in the years to come? Did others get mild cases of anthrax that went undiagnosed? And, perhaps most pressing, could those exposed to anthrax weeks ago still fall ill?